Back to Search Start Over

Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres

Authors :
M. Danei
Daniel Egle
Andreas Denk
P.J. van Dam
M. Rosselli Del Turco
U. Koehler
Andreas Schneeweiss
Johannes Ettl
G. Emons
Nadia Harbeck
E. Cretella
K. Van Eygen
Antonio Ponti
F. Badbanchi
Rachel Wuerstlein
Rainer Kimmig
A. Emons
V. Zanini
Dimitri Sarlos
A. Prové
G. Staelens
Mariano Tomatis
L. Regolo
Nicolai Maass
F. Stoeblen
Corrado Tinterri
P.A. van Dam
Christoph Rageth
Riccardo A. Audisio
C. Sohn
Wolfgang Gatzemeier
L.G. Bassani
Marion Kiechle
Robert E. Mansel
C. Mayr
Lorenza Marotti
K. Friedrichs
M. Daniaux
Sherko Kuemmel
Gianpiero Catalano
A. Van As
Jörg Heil
Donato Casella
Christian F. Singer
Peter Kern
F Lorenz-Salehi
EusomaDB Working Grp
Source :
European journal of cancer
Publication Year :
2016

Abstract

Aim of the study: The European Society of Breast Cancer Specialists (EUSOMA) has fostered a voluntary certification process for breast centres to establish minimum standards and ensure specialist multidisciplinary care. Prospectively collected anonymous information on primary breast cancer cases diagnosed and treated in the units is transferred annually to a central EUSOMA data warehouse for continuous monitoring of quality indicators (QIs) to improve quality of care. Units have to comply with the EUSOMA Breast Centre guidelines and are audited by peers. The database was started in 2006 and includes over 110,000 cancers from breast centres located in Germany, Switzerland, Belgium, Austria, The Netherlands, Spain, Portugal and Italy. The aim of the present study is assessing time trends of QIs in EUSOMA-certified breast centres over the decade 2006-2015. Materials and methods: Previously defined QIs were calculated for 22 EUSOMA-certified breast centres (46122 patients) during 2006-2015. Results: On the average of all units, the minimum standard of care was achieved in 8 of 13 main EUSOMA QIs in 2006 and in all in 2015. All QIs, except removal of at least 10 lymph nodes at axillary clearance and oestrogen receptor-negative tumours (T > 1 cm or N+) receiving adjuvant chemotherapy, improved significantly in this period. The desirable target was reached for two QIs in 2006 and for 7 of 13 QIs in 2015. Conclusion: The EUSOMA model of audit and monitoring QIs functions well in different European health systems and results in better performance of QIs over the last decade. QIs should be evaluated and adapted on a regular basis, as guidelines change over time. (C) 2017 Elsevier Ltd. All rights reserved.

Details

ISSN :
18790852 and 09598049
Volume :
85
Database :
OpenAIRE
Journal :
European journal of cancer (Oxford, England : 1990)
Accession number :
edsair.doi.dedup.....b7a26d97a33412fec88fc7525de74634